Actively Recruiting

Phase 1
Phase 2
Age: 1Year +
All Genders
NCT05295433

An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705

Led by ModernaTX, Inc. · Updated on 2025-12-23

56

Participants Needed

12

Research Sites

629 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objective of this study is to evaluate the long-term safety and clinical activity of mRNA-3705 administered to participants with isolated methylmalonic acidemia (MMA) due to methylmalonyl-coenzyme A mutase (MUT) deficiency who have previously participated in other clinical studies of mRNA-3705.

CONDITIONS

Official Title

An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705

Who Can Participate

Age: 1Year +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Completed the assigned dose regimen treatment time period in other clinical studies of mRNA-3705 or is eligible for early transition because of missing more than 3 consecutive doses due to COVID-19 vaccination during Study mRNA-3705-P101 Part 1
  • Completed the End of Treatment (EOT) Visit or End of Study Visit in Study mRNA-3705-P101 within 10 days before the first dose of mRNA-3705 in this extension study
Not Eligible

You will not qualify if you...

  • Not expected to receive clinical benefit from continued mRNA-3705 administration, in the opinion of the Investigator
  • Any clinical or laboratory abnormality or medical condition that may increase risk by participating, at the Investigator's discretion
  • History of liver and/or kidney transplant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 12 locations

1

UCLA Medical Center

Los Angeles, California, United States, 90095

Actively Recruiting

2

Lucile Packard Children's Hospital at Stanford

Palo Alto, California, United States, 94304

Actively Recruiting

3

Altman Clinical and Translational Research Institution

San Diego, California, United States, 92037

Actively Recruiting

4

Stollery Children's Hospital University of Alberta

Edmonton, Alberta, Canada, T6G 2R7

Actively Recruiting

5

Hospital For Sick Children

Toronto, Ontario, Canada, M5G 1X8

Actively Recruiting

6

Hôpital Necker - Enfants Malades APHP

Paris, France, 75015

Actively Recruiting

7

Erasmus MC

Rotterdam, Netherlands, 3015 AA

Actively Recruiting

8

Universitair Medisch Centrum Utrecht

Utrecht, Netherlands, 3584 CX

Actively Recruiting

9

Hospital Universitario Cruces

Barakaldo, Vizcaya, Spain, 48903

Actively Recruiting

10

Hospital Universitario 12 de Octubre

Madrid, Spain, 28041

Actively Recruiting

11

Birmingham Children's Hospital NHS Foundation Trust

Birmingham, United Kingdom, B4 6NH

Terminated

12

Royal Manchester Childrens Hospital

Manchester, United Kingdom, M13 9WL

Actively Recruiting

Loading map...

Research Team

M

Moderna WeCare Team

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705 | DecenTrialz